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Abstract (184/250) 
Free-living ambulation with accelerometer-based devices is an attractive methodology to assess 
habitual behaviour within Parkinson’s disease (PD). However, slowness of movement can contribute 
to difficulty in quantifying ambulatory/walking outcomes within this group by these devices. This 
study investigates the use of a commercial accelerometer device (activPAL™) in those with moderate 
PD to understand its proprietary software (inbuilt algorithm) limitations. The values provided by the 
proprietary software are evaluated in comparison to novel algorithms on the same raw data to examine 
limitations for use within this cohort. The bespoke algorithms help to alter sensitivity in outcomes 
stemming from the same accelerometer data while also highlighting how slight changes in algorithms 
can drastically inflate/deflate values. In general, results show that the proprietary software generally 
quantifies lower values of outcomes (step and bout count), which is similar to previous findings. 
Variations in algorithm functionality highlight large heterogeneity in bout and step counts resulting 
from a lack of how they are defined within the literature. The novel alternative ambulatory algorithms 
presented here should be considered for use on raw data from the activPAL™ in those with 
moderate/severe PD. 
 
 
Keywords: accelerometer; gait; bouts; free-living; habitual; algorithm; 
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1. Introduction 
Ambulatory activity (walking) is a useful measurement tool in neurodegenerative disorders, e.g. 
Parkinson’s disease (PD) [1, 2]. Monitoring community-based activity may better inform 
diagnosis/treatment compared to traditional clinical assessment due to the habitual (free-living) 
movement [3-6]. Currently, accelerometer-based devices are primarily used to quantify timed periods 
of walking (bouts), number of bouts and steps accumulated during longitudinal monitoring (i.e. 7 
days). Devices can be worn in a number of anatomical locations [7, 8] each generating a notable 
change in signal acceleration [9] and therefore requiring site specific analytical methods (algorithms). 
Typically devices are worn at or near the waist/lower back to examine whole body movement, but 
limitations in current algorithms prohibit robust segmentation of upright activity (standing and 
sedentary, i.e. sitting) with a device at that location and orientation [10].  
An alternative attachment location is the upper thigh which easily segments between standing and 
sedentarism due to device placement and orientation [11, 12]. However, this location is reliant on 
single limb movement potentially underestimating step count and bout definition during prolonged 
free-living assessment. Moreover, this could be exacerbated by rigid analytical methods (e.g. fixed 
thresholds) more suited to higher intensity ambulation rather than slow, less clearly defined walking 
as experienced within PD [13]. One commercial device worn on the thigh includes the activPAL™ 
which has been validated in young adults for bout length/count (at a resolution of 1 minute) during 
prolonged free-living activity [14] or scripted tasks [11]. However, large errors have been reported for 
estimated step count [10] from the same device during similar unstructured activity at slow speeds. To 
date no study has examined why the errors exist which may primarily stem from its front end 
proprietary software (internal algorithm). Nor has any study previously examined the utility of its raw 
accelerometer data for walking assessment in those with moderate/severe PD. 
Therefore, the primary purpose of this study is to examine quantified bouts and step count from 
the proprietary software of the activPAL™ in those with moderate PD to robustly examine the device 
in those with slower less clearly defined walking. Secondary, values from the proprietary software 
were compared against suggested novel alternative algorithms used to investigate the suitability of the 
raw activPAL™ acceleration data and its applicability in quantifying PD ambulation/walking during 
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free-living. We discuss all algorithms for use with raw activPAL™ data and make recommendations 
for future free-living PD walking assessment with this device. 
 
2. Algorithms 
2.1 Participants 
PD participants 18 months post diagnosis were recruited from the ICICLE-GAIT study [3], a 
collaborative study with ICICLE-PD1 conducted between June 2009 and December 2011 [15]. The 
study was approved by the Newcastle and North Tyneside 1 Research Ethics Committee and 
Newcastle upon Tyne Hospitals NHS Foundation Trust (09/H0906/82). All participants gave their 
informed written consent. Demographics and motor-based clinical measures were recorded: self-
report freezing of gait (FOG), self-efficacy balance confidence scale (Activities Balance Self 
Confidence Scale, ABCs), severity of motor symptoms (Hoehn and Yahr scale, H&Y) and section III 
(motor examination) of the modified Movement Disorder Society version of the Unified Parkinson’s 
Disease Rating Scale (MDS-UPDRS III).  
 
2.2 Equipment 
The activPAL™2 (53.0 × 35.0 × 7.0mm, 20g, 10Hz, 8bit,  ±2g) is a uni-axial accelerometer-based  
device with its output expressed as 64 analog to digital (A/D) units per 1g (gravity, 1g = 9.81ms-2, i.e. 
1 A/D unit equates to 16mg). It was attached, in accordance with manufactures guidelines, to the mid-
line of the upper thigh by a hydrogel adhesive (PALStickies3) and covered with Hypafix3 tape [16]. 
Participants were instructed to remove devices only during bathing and were provided with 
replacement adhesives and tape to re-attach each.  
 
2.3 Data processing 
Data from the device were downloaded via its graphical user interface program. Firstly, the 
program segmented, quantified and presented the data with outcomes according to its regular use in 
                                                          
1 Incidence of Cognitive Impairment in Cohorts with Longitudinal Evaluation-Parkinson’s disease 
2 PAL Technologies, Glasgow, UK 
3 BSN Medical Limited, Hull, UK 
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an Excel4 (event) file estimating time spent sedentary (sitting/lying), standing, stepping and number of 
steps. Stepping data only in this format were analysed via MATLAB®, as described previously 
(Program 1) [3, 17, 18], Fig. 1. Secondly, the software exported the raw accelerometer-based 
activPAL™ data to a comma separated value format (.csv). That raw format was processed by a 
bespoke MATLAB® program (Program 2), implementing numerous variations on quantifying PD 
walking: importing the raw accelerometer data, identifying periods of upright from sitting/lying 
(sedentary), segmenting standing from stepping and quantifying walking outcomes. A representation 
of data analysis flow is presented in Fig. 1. 
 
Figure 1: Data processing flow algorithm and analysis performed by the MATLAB® programs. 
 
2.4 Alternate ambulatory algorithms 
Raw data were analysed utilising a number of algorithm configurations consisting of three stages: 
(i) segmenting sitting/lying (sedentary) from standing/walking (upright) by applying a predetermined 
threshold (value = 20 A/D units, Fig. 2a&b), (ii) applying a SD threshold (3.5 A/D units) of the 
complete bout to identify standing from walking and (iii) quantify stepping by considering a number 
of different configurations, below. All thresholds were chosen from visual observation based on the 
                                                          
4 Microsoft Corp., Redmond, WA, USA 
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mean value of the raw data while standing (approx. 150 AD units) and lower/upper limits which may 
be sensitive to step detection (peaks), selected as -20/-25 and +20/+25, Fig. 2. 
1. Applying two random thresholds (Algorithm #1 (150-25) = 125 and #2 (150-20) = 130) on 
the negative peaks of a standing/stepping bout (Fig. 2c-i). Peaks (in all cases) were found 
using the MATLAB® findpeaks function, which had the potential to yield many peaks within 
the same step location. Thus, the ‘MinPeakDistance’ parameter (value = 8 samples or 800ms 
based on device sampling rate) within the function was implemented only here to eliminated 
smaller peaks within close proximity to a ‘step’ (i.e. true negative peak). 
2. Positive/negative peak detection criteria to quantify a step. Based on the location of the 
device, a step was defined in the order of a forward (positive, green circle) and backward 
(negative, red circle) swing within the signal (Fig. 2c) based on positive/negative peak 
thresholds (Algorithm #3 = 125/175 and #4 = 130/170). 
3. Positive/negative peak detection criteria to quantify a step excluding 1 single step. This 
method (algorithm #5) is similar to that in #3 (125/175), but excluded a bout with a single 
step (e.g. Fig. 2c i-ii - d). This was implemented to remove what may be termed a non-
purposeful step/walk or single step in a fixed location. 
4. Positive/negative peak detection criteria to quantify a step based on a within bout adaptable 
threshold (algorithm #6). This novel method estimated the mean and SD per individual 
stepping bout to define a peak threshold for that bout (mean of the bout ± SD of the same 
bout). The SD was estimated from all values of the bout >100 to account for very large 
estimations based on a brief period (1-2s) of crouching/kneeling that may occur: manual 
inspections of the signals showed brief periods where the general trend of the signal 
approached the sedentary/upright threshold (i.e. 20 A/D units), perhaps due to picking an 
object from the floor. Removal of continuous values below 100 ensured the SD value 
remained small to detect smaller peak missed by previous methods, Fig. 2c-iii. Thus, 
individual (unique) mean and SD values were calculated for each bout, enabling an adaptable 
threshold to be applied specific to each bout of walking. This may be particularly useful for 
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ensuring accurate step quantification due to slowness of walking speed in older adult during 
different conditions or pathological populations with varying/deteriorating walking ability. 
5. It has been shown that the proprietary software for the device applies an internal threshold 
between stepping bouts that group bouts before/after a brief bout of standing, i.e. a maximum 
resting period (MRP) of 6s [19]. The above Algorithms were implemented with the same 6s 
methodology, but Algorithms #7 and #8 reduced this to 3s and 1s, respectively. (The SD 
thresholding method per bout (Algorithm 6, above) was used here). 
Bout length (period of time stepping/walking) was calculated from the time of the first step to the 
last step based on the aforementioned algorithms with the addition of a 1.6s buffer to account for step 
initiation/termination. This method was based upon inspection of the raw data and parallels drawn to 
the outcomes from the proprietary software. 
8 
 
 
Figure 2: 
a. Raw free-living uniaxial accelerometer for 7 days 
b. Zoomed data of sitting/lying and standing/stepping bouts based on the orientation and variations 
within the signal, respectively 
c. Zoomed standing/stepping bout (right) and enlarged examples of step detection based on 
Algorithm #1 (i), Algorithm #3 (ii) and Algorithm #6/7/8 (iii). (Note: The portion of this signal 
corresponds to Fig 3). 
d. Elimination of a one-step bout, algorithm #5. 
e. Possible bouts of walking/stepping and steps unquantified by the proprietary software and 
algorithms #1-5, yet identified by algorithm #6/7/8. 
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3. Results 
Over 55.5 days (approx. 80000 minutes) were recorded, the device failed to record for just over 
half a day on one occasion. Participants (n=8) demographic, clinical and cognitive descriptors are 
shown in Table 1. All participants reported no FOG. Compared to reference [20] control data (shown 
in italics), participants presented with slightly lower confidence in their balance (ABCs: 86.2 v 91.3). 
All participants presented with H&Y II with a mean score of 27.9 on the MDS-UPDRS III, 
symptomatic of moderate PD [3]. 
Table 1: Participant demographic and clinical characteristics 
Characteristic Mean ± SD 
M/F (n) 4 / 4 
Age (years) 68.0 ± 8.4 
Height (m) 1.7 ± 0.1 
BMI (Kg/m2) 26.0 ± 4.3 
ABCs (0-100%) 86.2 ± 15.6 
Hoehn & Yahr (n) H&Y I – 0 
 H&Y II – 8 
 H&Y III – 0 
MDS-UPDRS III 27.9 ± 6.9 
BMI: body mass index, ABCs: activities specific 
balance confidence scale, UPDRS: Unified 
Parkinson’s Disease Rating Scale 
 
There was a 128% increase in total time walked from (proprietary) 523.3mins/week to (algorithm 
#2) 1198.1mins/week depending on algorithm configuration, Table 2. Slight fixed thresholding 
variation (125 vs. 130 and 130/170 vs. 125/175) increased total walking time between 124.8 (454.3-
329.5) to 200.3 (1198.1-997.8) mins/week, (or up to 30mins/day), respectively. 
Bout length times (ranges) were comparable and consistent except for Algorithms #3, #5 and #8 
suggesting peak thresholds (125/175) and a MRP gap of 1s between bouts for this population are 
unsuitable. Moreover, if allowing for a MRP between bouts, the value/threshold should be in excess 
of 1s (i.e. 1 stride) accounting for device location and inter limb dependency to define 
ambulation/walking. Bout count almost doubled (2955 to 5256) due to the detection of larger number 
of shorter bouts with the increased sensitivity in possible step detection.  
Algorithm variations resulted in a 79% increase in steps detection within the device (proprietary: 
19,041 to algorithm #2: 34,126) due to an increased sensitivity approach within the same signal, Table 
2 and Fig. 2c. However, it was noted that Algorithm #1 and #2 (fixed negative thresholding) resulted 
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in a possible ‘false’ steps due to what appeared to be brief periods of couching/kneeling and hence 
change in orientation of the device (trend in acceleration signal) dropping acceleration below the 
sedentary/upright threshold. 
<Table 2, end of document> 
 
3. Discussion 
The purpose of this study was to investigate the use of the activPAL™ to quantify slower, reduced 
quality of ambulation/walking as experience in those with moderate PD. For the purposes of this 
study, bout and step outcomes from its proprietary software were compared to other novel algorithms 
suggested for use on the raw accelerations of the same device. This was a novel aspect of the study 
and to the authors knowledge no previous work has investigated or suggested alternative algorithms 
for the raw activPAL™ data. Bout length (range) was consistent for 6 of the algorithms (inc. 
proprietary software), yet bout and step count varied greatly throughout prompting an urgent need to 
clarify the definition of ambulation in free-living conditions, especially in PD where clarity of 
movement is less clear/distinctive. Moreover, this highlights the weakness of utilising fixed thresholds 
when pragmatically deploying devices across a range of walking abilities. However, the raw data 
captured by the activPAL™ has utility to quantify ambulation in moderate/severely affected PD by 
applying the alternate algorithm(s) suggested here rather than accepting values from the proprietary 
software which may underestimate. 
 
Bout length 
Applying alternative algorithms to the device resulted in the identification and increased length 
and number of possible gait bouts (Fig 2e and Fig. 3A), Table 2. Yet, values (maximum range) were 
similar to those generated by the proprietary software. Previous studies have evaluated the bout length 
properties of the device to other accelerometer-based equipment at 1 minute epochs or visual 
inspection [11, 14] with good accuracy, but never in free-living older adults with PD. However, the 
similarities between bout lengths here suggest algorithms are stable and comparable for defining bout 
length in PD.  
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Algorithm #6 (7 and 8) seems the most logical for future use when considering the functionality 
of the device, placement on the thigh and patient cohort: true step identification due to the reliance on 
positive/negative swings in the acceleration signal and adaptable threshold to account for any change 
in speed/intensity due to fatigue or accompanied walking. Notable areas of activity (possible gait 
initiation) were identified (Fig. 3, gold circles C) which could impact the length of a bout (total 
walking time, number of steps included) but were not detected by the algorithms presented here, even 
when using a variable within bout thresholding method (i.e. use of SD rather than predetermined 
values of 120/170 and 125/175). Sensitivity could be increased by altering the first SD threshold 
(stage ii) to segment standing from stepping. For more advanced PD (H&Y III) this could possibly be 
revised down (e.g. 2.5) to account for even slower ambulation/walking acceleration profiles. 
Additionally, although self-efficacy FOG wasn’t reported, quantification of these regions may be 
useful in capturing and exploring quality of initiation, termination or festination of walking with these 
raw data. 
 
Bout count (and total time) 
The proprietary software of the device often failed to quantify short or slower less intense bouts, 
which also impacted total (accumulated) ambulatory time, Fig. 2e or 3C. Three bouts are highlighted, 
yet only 2 were recognised by the proprietary software denoted by the green (start) and red (end) 
lines. However, the centre bout (Fig. 3B) and step (Fig. 3D) closely resemble a short bout that went 
unrecognised, which were common occurrences from manual visual inspection of all participant 
signals. However, alternative algorithms increased bout count to include those depicted in Fig 2e, Fig 
3A. These included the variations within the MRP (1, 3 and 6s) between recognised walking bouts 
which has been previously investigated and inherent within this device [19]. This influenced bout 
count as well as total time and should be considered within moderate/severe PD due to functional 
ability and/or fatigue. However, clear definitions on what defines (i) an individual walking bout or (ii) 
separate bouts from another due to any length of upright/standing resting period, is yet to be ratified 
within the literature and should be considered in future walking recognition algorithms. 
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Figure 3: 
The same portion of the raw accelerometer signal corresponding to Fig 2c. Two detected bouts with 
start/end times determined by its proprietary software and inbuilt threshold, total number of detected 
steps = 6 (between vertical green/red lines). Applying two different algorithms (#1 and #2) results in: 
increased bout lengths (A), detection of a new bout (B) and an increased number of steps (D, lilac, 
threshold of 125 (#1): n = 8), or (E, purple, threshold of 130 (#2): n = 15). 
 Note #1: the proprietary software failed to detect a single (possible) step within the area of interest 
B, but was classified (step/bout) by some of suggested methodology, where appropriate. 
 Note #2: The areas of interest C (gold circles) not quantified as steps by any of the algorithms 
which may be useful for examining poor gait initiation in this cohort.  
 
 
Step count 
While the exact functionality of the activPAL™ proprietary software is unknown, its step accuracy 
were recently shown to a lower number of step count during scripted and outdoor use under different 
speeds (slow and fast) in different ages [10, 21]. The alternate algorithms presented in this study may 
help in quantifying steps in those with moderate/severe motor disorders from the raw data. While 
inclusion of less purposeful steps (i.e. shuffling) creates an abundance of possible data to examine 
gait, it can blur the lines between ad-hoc/sporadic gait (e.g. lateral movement due to cooking within a 
kitchen), reduced clarity of walking due to cognitive loading (e.g. dual tasking) and 
continuous/purposeful walking. Moreover, defining steps within or between cohorts need to be 
considered for the population in question. The quantification of steps during sporadic walking within 
PD may be more informative and abundant [22] than those accumulated during a few continuous 
bouts, more representative of ability rather than disease severity. Participants within this study 
presented moderate symptoms (H&Y II, MDS-UPDRS III 27.9) and could be described as active but 
having some degree of motor impairment suggesting that the commercial algorithm to quantify their 
steps (and bouts) as inadequate. This is supported by the proposed alternative methods of step 
detection form the same device (Algorithms #1, 2, 6-8) where a slight change of threshold or 
application of a novel adaptable threshold per bout resulted in increased step count.  
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Advantages and limitations of proposed algorithms 
The proposed methodology of positive/negative peak reliance to define a step based on device 
location (thigh) seemed logical to best represent the functional mechanics of walking. Moreover, the 
novel within bout threshold to account for stepping performance (in that bout of walking) seemed 
equally logical to account for variations in gait under different environmental conditions, improved 
step detection due to accompanied walks and/or dual tasking. However, ambulation is presented here 
in the general context (all walking) and in reality extends to more levels of complexity, such as stair 
ascent/descent and walking on uneven terrain which may negatively impact step count based upon the 
applied methodology assuming level walking [10].  
 
4. Conclusion 
Comparable bout length times were found across all algorithms suggesting its use as a robust 
outcome from the device. Yet it was possible to generate large variation in bout and step count from 
the same acceleration data, stemming from short bouts and slight variations in methods. Thorough 
investigation of the data found that numerous ambulatory/walking events were unaccounted for which 
impacted algorithm agreement. However, clear definition of walking events (definition of a step and 
start/end of a bout) from free-living data needs to be ratified within the literature enabling more 
clarified habitual walking assessment. It has been shown that the activPAL™ commercial software 
may be unable to account for all bout and step count in moderate PD due to reduced clarity of 
movement with its values alluding to more purposeful walking. Yet, examination of the same raw data 
enables the researcher to apply alternate, more stringent and novel methodologies (like those proposed 
here) and should be considered with future use of the device within moderate/severe PD. All 
methodologies presented here should be validated to a gold standard video/observer and constitute 
ongoing work. 
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Tables 
 
Table 2: Median (Range) of walking/stepping outcomes for 7 days with different algorithm configurations 
Configuration Total time (mins) Bout length (mins) Bout count Step count 
Proprietary software 523.3 (254.9 – 807.6) 0.1 (0.0 – 21.0) 2955 (1580 – 4051) 19041 (8748 – 30112) 
Algorithm #1: negative peak threshold (125) 997.8 (514.5 – 1335.2) 0.1 (0.1 – 24.8) 3857 (2161–5097) 27624 (14125 – 40688) 
Algorithm #2: negative peak threshold (130) 1198.1 (569.2 – 1462.2) 0.1 (0.1 – 24.8) 3878 (2151–5316) 34126 (16223 – 44444) 
Algorithm #3: +/- peak dependency (125/175) 329.5 (123.9 – 602.4) 0.1 (0.1 – 9.0) 1794 (872 – 3328) 10906 (3548 – 20517) 
Algorithm #4: +/- peak dependency (130/170) 454.3 (221.6 – 796.1) 0.1 (0.1 – 20.9) 2163 (1357 – 3802) 14725 (6620 – 26388) 
Algorithm #5: +/- peak dependency (125/175) - 1 step bout  301.7 (101.2 – 512.6) 0.1 (0.1 – 9.0) 1394 (690 – 2346) 10506 (3205 – 19931) 
Algorithm #6: +/- peak dependency (SD threshold), 6s gap 858.3 (446.0 – 1276.4) 0.2 (0.1 – 20.9) 3342 (1613 – 5304) 29047 (15767 – 40140) 
Algorithm #7: +/- peak dependency (SD threshold), 3s gap 795.6 (410.0 – 1171.1) 0.1 (0.1 – 20.7) 4301 (2106 – 6512) 29034 (15767 – 40136) 
Algorithm #8: +/- peak dependency (SD threshold), 1s gap 765.0 (392.6 – 1127.6) 0.1 (0.1 – 13.0) 5256 (2634 – 7810) 29034 (15767 – 40136) 
 
